Amos Bar-shalev - Net Worth and Insider Trading
Amos Bar-shalev Net Worth
The estimated net worth of Amos Bar-shalev is at least $222 dollars as of 2024-11-13. Amos Bar-shalev is the Director of Protalix BioTherapeutics Inc and owns about 168 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $222. Details can be seen in Amos Bar-shalev's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amos Bar-shalev has not made any transactions after 2009-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Amos Bar-shalev
Amos Bar-shalev Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amos Bar-shalev owns 1 companies in total, including Protalix BioTherapeutics Inc (PLX) .
Click here to see the complete history of Amos Bar-shalev’s form 4 insider trades.
Insider Ownership Summary of Amos Bar-shalev
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2020-01-20 | director |
Amos Bar-shalev Latest Holdings Summary
Amos Bar-shalev currently owns a total of 1 stock. Amos Bar-shalev owns 168 shares of Protalix BioTherapeutics Inc (PLX) as of December 2, 2009, with a value of $222.
Latest Holdings of Amos Bar-shalev
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2009-12-02 | 168 | 1.32 | 222 |
Holding Weightings of Amos Bar-shalev
Amos Bar-shalev Form 4 Trading Tracker
According to the SEC Form 4 filings, Amos Bar-shalev has made a total of 0 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years. The most-recent trade in Protalix BioTherapeutics Inc is the acquisition of 168 shares on December 2, 2009, which cost Amos Bar-shalev around $14,263.
Insider Trading History of Amos Bar-shalev
- 1
Amos Bar-shalev Trading Performance
GuruFocus tracks the stock performance after each of Amos Bar-shalev's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amos Bar-shalev is -6.69%. GuruFocus also compares Amos Bar-shalev's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amos Bar-shalev within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amos Bar-shalev's insider trading performs compared to the benchmark.
Performance of Amos Bar-shalev
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.8 | | | | | |
| Relative Return to S&P 500(%) | -15.33 | | | | | |
Amos Bar-shalev Ownership Network
Ownership Network List of Amos Bar-shalev
Ownership Network Relation of Amos Bar-shalev
Amos Bar-shalev Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
Amos Bar-shalev is the director of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, Amos Bar-shalev made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 64,516 shares made by Dror Bashan ,
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 64,516 shares were bought by its insiders, resulting in a net purchase of 64,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
Amos Bar-shalev Mailing Address
Above is the net worth, insider trading, and ownership report for Amos Bar-shalev. You might contact Amos Bar-shalev via mailing address: C/o Protalix Biotherapeutics, Inc., 2 Snunit St, Science Park, Pob 455, Carmiel L3 20100.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
